866404-31-1
Product Name:
XJB-5-131
Synonyms:
;Boc-Leu-Ψ[€-CH=CH]-D-Phe-Pro-Val-Orn(Cbz)-TEMPO;XJB 5-131
Inquiry
COMPUTED DESCRIPTORS
| Molecular Weight | 959.2 g/mol |
|---|---|
| XLogP3 | 7.8 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 24 |
| Exact Mass | 958.60175215 g/mol |
| Monoisotopic Mass | 958.60175215 g/mol |
| Topological Polar Surface Area | 189 Ų |
| Heavy Atom Count | 69 |
| Formal Charge | 0 |
| Complexity | 1700 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
description
XJB-5-131 is a peptidomimetic that is an inhibitor of ferroptosis and prevents the onset of motor decline in a mouse model for Huntington's disease. It has a role as a ferroptosis inhibitor, a radical scavenger, a peptidomimetic and a radiation protective agent. It is a member of aminoxyls, a secondary carboxamide, a L-valine derivative, a L-proline derivative, a L-ornithine derivative, a tert-butyl ester, a benzyl ester, a member of piperidines, an olefinic compound and a carbamate ester.